see more

Scott McCauley, associate scientist at the Gilead Sciences Inc., makes human proteins at the Gilead laboratory in Foster City, California, U.S., on Wednesday, Aug. 10, 2011. Gilead Sciences Inc., the world's biggest maker of AIDS drugs, is re-entering the market for cancer medicines a decade after selling its oncology unit. Photographer: David Paul Morris/Bloomberg via Getty Images

Scott McCauley, associate scientist at the Gilead Sciences Inc., makes human proteins at the Gilead laboratory in Foster City, California, U.S., on Wednesday, Aug. 10, 2011. Gilead Sciences Inc., the world's biggest maker of AIDS drugs, is re-entering the market for cancer medicines a decade after selling its oncology unit. Photographer: David Paul Morris/Bloomberg via Getty Images